32989-69-8 Usage
Molecular weight
229.28 g/mol
Chemical class
Pyrrolidine derivative
Functional groups
Nitro group (-NO2) and phenyl group (C6H5)
Nitroalkene derivative
Yes
Potential applications
Pharmaceutical and industrial applications
Presence of nitrophenyl group
Yes, which makes it potentially useful for the synthesis of various biologically active compounds
Safety concerns
Potential health hazards if not properly managed and used in a controlled environment
Stereochemistry
(E)-2-(2-nitrophenyl)ethenyl group, indicating the presence of a double bond with trans configuration
Solubility
Not mentioned in the material provided, but generally, pyrrolidine derivatives are soluble in organic solvents like ethanol, methanol, and dichloromethane
Stability
Not mentioned in the material provided, but generally, nitro compounds can be sensitive to heat and light, so it is advisable to store in a cool, dark place and handle with care
Reactivity
Not mentioned in the material provided, but nitro compounds can be reactive, especially with reducing agents and nucleophiles, so proper precautions should be taken during synthesis and handling
Purity
Not mentioned in the material provided, but the purity of the compound should be confirmed through analytical techniques like NMR, HPLC, or mass spectrometry before use in any application
Structural features
The compound consists of a pyrrolidine ring fused to an ethenyl group, which is connected to a 2-nitrophenyl group through a carbon-carbon double bond
Check Digit Verification of cas no
The CAS Registry Mumber 32989-69-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,9,8 and 9 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 32989-69:
(7*3)+(6*2)+(5*9)+(4*8)+(3*9)+(2*6)+(1*9)=158
158 % 10 = 8
So 32989-69-8 is a valid CAS Registry Number.
32989-69-8Relevant articles and documents
COMPOUNDS USEFUL IN HIV THERAPY
-
Page/Page column 139, (2020/06/19)
The invention relates to compounds of Formula (I), (Ia), (Ib), (II) or (III), salts thereof, pharmaceutical compositions thereof, as well as therapeutic methods of treatment and prevention.
New entry to convertible isocyanides for the Ugi reaction and its application to the stereocontrolled formal total synthesis of the proteasome inhibitor omuralide
Gilley, Cynthia B.,Buller, Matthew J.,Kobayashi, Yoshihisa
, p. 3631 - 3634 (2008/02/12)
The development of a new convertible isocyanide, indole-isocyanide, for ready access to pyroglutamic acids culminated in the formal total synthesis of the proteasome inhibitor omuralide featuring a stereocontrolled Ugi reaction. Indole-isocyanide was name
Strategies for the synthesis of N-(azacycloalkyl)bisindolylmaleimides: Selective inhibitors of PKCβ
Faul, Margaret M.,Grutsch, John L.,Kobierski, Michael E.,Kopach, Michael E.,Krumrich, Christine A.,Staszak, Michael A.,Udodong, Uko,Vicenzi, Jeffrey T.,Sullivan, Kevin A.
, p. 7215 - 7229 (2007/10/03)
N-(Azacycloalkyl)bisindolylmaleimides 1 have been identified to be selective inhibitors of PKCβ. This manuscript will describe the synthetic approaches employed to prepare this class of compounds that resulted in development of efficient methods for prepa
